X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-19 | MCK | McKesson Corp | Martinez Maria | Dir | S - Sale | $939.87 | -349 | 301 | -54% | -$328,013 | ||||||
2026-02-20 | WAB | Westinghouse Air Brake Technologies Corp | Mendonca Rogerio | Pres, Equipment Group | S - Sale | $264.21 | -3,500 | 10,101 | -26% | -$924,719 | ||||||
| D | 2026-02-19 | EQ | Equillium, Inc. | Zedelmayer Christine | SVP, COO | S - Sale+OE | $1.76 | -185,937 | 191,444 | -49% | -$328,104 | |||||
2026-02-20 | RGLD | Royal Gold Inc | Hayes William M. | Dir | S - Sale | $277.07 | -4,173 | 6,129 | -41% | -$1,156,213 | ||||||
| D | 2026-02-20 | KEX | Kirby Corp | Husted Amy D. | EVP GC, Sec | S - Sale+OE | $129.33 | -11,667 | 14,814 | -44% | -$1,508,893 | |||||
| D | 2026-02-19 | KEX | Kirby Corp | Davis Barry E | Dir | S - Sale+OE | $128.51 | -8,480 | 45,723 | -16% | -$1,089,765 | |||||
2026-02-19 | GF | New Germany Fund Inc | Saba Capital Management, L.P. | 10% | P - Purchase | $12.20 | +17,044 | 2,512,366 | +1% | +$207,937 | ||||||
| M | 2026-02-19 | PDX | Pimco Dynamic Income Strategy Fund | Saba Capital Management, L.P. | 10% | S - Sale | $20.36 | -56,991 | 6,500,174 | -1% | -$1,160,053 | |||||
| M | 2026-02-19 | ECAT | Blackrock Esg Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% | S - Sale | $15.04 | -75,148 | 23,669,210 | 0% | -$1,130,031 | |||||
2026-02-19 | CBLL | Ceribell, Inc. | Parvizi Josef | Dir | S - Sale | $20.27 | -16,714 | 1,999,651 | -1% | -$338,793 | ||||||
2026-02-20 | RCG | Renn Fund, Inc. | Stahl Murray | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.84 | +1,134 | 1,041,508 | 0% | +$3,221 | ||||||
2026-02-20 | WTS | Watts Water Technologies Inc | Horne Timothy P | 10% | S - Sale | $330.04 | -7,500 | 7,500 | -50% | -$2,475,300 | ||||||
2026-02-19 | ITRI | Itron, Inc. | Deitrich Thomas | Pres, CEO | S - Sale | $99.54 | -56,095 | 400,134 | -12% | -$5,583,612 | ||||||
2026-02-19 | ITRI | Itron, Inc. | Hooper Joan S | SVP, CFO | S - Sale | $99.54 | -15,293 | 124,196 | -11% | -$1,522,242 | ||||||
2026-02-19 | ITRI | Itron, Inc. | Marcolini John F. | SVP, Networked Solutions | S - Sale | $99.54 | -6,948 | 26,912 | -21% | -$691,593 | ||||||
2026-02-19 | ITRI | Itron, Inc. | Patrick Justin K | SVP, Device Solutions | S - Sale | $99.54 | -4,930 | 34,344 | -13% | -$490,725 | ||||||
2026-02-19 | ITRI | Itron, Inc. | Pulatie-Hahn Laurie Ann | SVP, HR | S - Sale | $99.54 | -3,755 | 33,679 | -10% | -$373,767 | ||||||
2026-02-19 | ITRI | Itron, Inc. | Reeves Donald L. III | SVP, Outcomes | S - Sale | $99.54 | -5,419 | 33,140 | -14% | -$539,399 | ||||||
2026-02-19 | ITRI | Itron, Inc. | Ware Christopher E. | SVP, GC, Corp. Secretary | S - Sale | $99.54 | -4,486 | 31,806 | -12% | -$446,530 | ||||||
| D | 2026-02-20 | CHCO | City Holding Co | Hageboeck Charles R | Pres, CEO | S - Sale+OE | $125.33 | -1,275 | 51,218 | -2% | -$159,792 | |||||
| D | 2026-02-19 | PG | Procter & Gamble Co | Whaley Susan Street | GC, Secy | S - Sale+OE | $159.46 | -1,809 | 36,805 | -5% | -$288,454 | |||||
2026-02-20 | FINS | Angel Oak Financial Strategies Income Term Trust | Cohen IRA P | Dir | P - Purchase | $13.17 | +379 | 379 | New | +$4,991 | ||||||
2026-02-20 | TTMI | Ttm Technologies Inc | Gridley Catherine A | EVP, A, D Sector Pres | S - Sale | $105.94 | -20,000 | 78,645 | -20% | -$2,118,800 | ||||||
2026-02-19 | LH | Labcorp Holdings Inc. | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale | $277.94 | -666 | 1,852 | -26% | -$185,108 | ||||||
2026-02-19 | PMN | Promis Neurosciences Inc. | Kaplan Johanne | Chief Development Officer | P - Purchase | $15.35 | +1,629 | 3,941 | +70% | +$25,005 | ||||||
2026-02-20 | PODD | Insulet Corp | McEvoy Ashley | Pres, CEO | P - Purchase | $239.35 | +4,300 | 13,920 | +45% | +$1,029,205 | ||||||
| M | 2026-02-19 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.47 | +150,000 | 51,558,909 | 0% | +$219,755 | |||||
| D | 2026-02-19 | CNX | Cnx Resources Corp | Lanigan Bernard Jr | Dir | S - Sale+OE | $40.60 | -46,119 | 1,420,851 | -3% | -$1,872,224 | |||||
2026-02-20 | CVRX | Cvrx, Inc. | Jain Mudit K. | Dir | P - Purchase | $6.36 | +46,800 | 985,833 | +5% | +$297,592 | ||||||
2026-02-19 | TEM | Tempus Ai, Inc. | Lefkofsky Eric P | CEO, COB, 10% | S - Sale | $58.89 | -179,837 | 38,166,551 | 0% | -$10,589,918 | ||||||
| D | 2026-02-19 | FLD | Fold Holdings, Inc. | Repass Wolfe | CFO | S - Sale+OE | $1.48 | -21,857 | 176,329 | -11% | -$32,436 | |||||
| M | 2026-02-19 | JCTC | Jewett Cameron Trading Co Ltd | Oregon Community Foundation | 10% | S - Sale | $1.81 | -46,250 | 785,959 | -6% | -$83,767 | |||||
| D | 2026-02-18 | EXEL | Exelixis, Inc. | Wyszomierski Jack L | Dir | S - Sale+OE | $44.01 | -99,574 | 279,942 | -26% | -$4,382,252 | |||||
2026-02-20 | SOFI | Sofi Technologies, Inc. | Keough Kelli | EVP, GBUL, SIPS | S - Sale | $18.87 | -9,755 | 293,725 | -3% | -$184,118 | ||||||
| D | 2026-02-12 | TLPH | Talphera, Inc. | Angotti Vincent J. | CEO | P - Purchase | $0.81 | +105,364 | 577,395 | +22% | +$85,587 | |||||
| D | 2026-02-12 | TLPH | Talphera, Inc. | Aslam Shakil | Chief Medical Officer | P - Purchase | $0.81 | +35,000 | 83,178 | +73% | +$28,431 | |||||
| D | 2026-02-12 | TLPH | Talphera, Inc. | Dasu Badri N | Chief Engineering Officer | P - Purchase | $0.81 | +35,000 | 73,884 | +90% | +$28,431 | |||||
| D | 2026-02-12 | TLPH | Talphera, Inc. | Asadorian Raffi | CFO | P - Purchase | $0.81 | +45,000 | 179,579 | +33% | +$36,554 | |||||
2026-02-19 | NOC | Northrop Grumman Corp /De/ | Simpson Kathryn G | Corp VP, GC | S - Sale | $727.62 | -194 | 874 | -18% | -$141,158 | ||||||
2026-02-18 | ALGN | Align Technology Inc | Morici John | EVP, CFO | S - Sale | $189.31 | -7,969 | 8,237 | -49% | -$1,508,646 | ||||||
2026-02-19 | AMGN | Amgen Inc | Busch Matthew C. | VP, Finance, CAO | S - Sale | $375.79 | -1,000 | 3,423 | -23% | -$375,790 | ||||||
2026-02-20 | WY | Weyerhaeuser Co | O'Rourke James Calvin | Dir | P - Purchase | $25.35 | +4,000 | 28,661 | +16% | +$101,400 | ||||||
| M | 2026-02-19 | WRB | Berkley W R Corp | Mitsui Sumitomo Insurance Co Ltd | 10% | P - Purchase | $70.70 | +505,582 | 57,668,620 | +1% | +$35,744,460 | |||||
2026-02-19 | H | Hyatt Hotels Corp | Bottarini Joan | See Remarks | S - Sale | $166.61 | -1,825 | 12,881 | -12% | -$304,063 | ||||||
2026-02-20 | RPID | Rapid Micro Biosystems, Inc. | Wilson John J. Addington | COO | S - Sale | $3.92 | -5,403 | 326,365 | -2% | -$21,196 | ||||||
2026-02-20 | RPID | Rapid Micro Biosystems, Inc. | Wirtjes Sean M | CFO | S - Sale | $3.92 | -17,254 | 563,674 | -3% | -$67,687 | ||||||
2026-02-19 | RPID | Rapid Micro Biosystems, Inc. | Spignesi Robert G. Jr. | Pres, CEO | S - Sale | $3.89 | -38,327 | 1,187,770 | -3% | -$148,912 | ||||||
| D | 2026-02-18 | CRWV | Coreweave, Inc. | Venturo Brian M | Chief Strategy Officer | S - Sale+OE | $94.57 | -281,250 | 611,446 | -32% | -$26,596,915 | |||||
2026-02-18 | NKTR | Nektar Therapeutics | Zalevsky Jonathan | Chief R, D Officer | S - Sale | $73.00 | -180 | 21,174 | -1% | -$13,140 | ||||||
2026-02-18 | NKTR | Nektar Therapeutics | Robin Howard W | Pres, CEO | S - Sale | $73.00 | -423 | 75,517 | -1% | -$30,879 | ||||||
2026-02-20 | LUMN | Lumen Technologies, Inc. | Linear Diankha | Dir | S - Sale | $7.89 | -45,000 | 198,229 | -19% | -$355,050 | ||||||
2026-02-19 | NE | Noble Corp Plc | Barker Richard B. | EVP, CFO | S - Sale | $42.96 | -20,000 | 314,781 | -6% | -$859,200 | ||||||
2026-02-19 | NE | Noble Corp Plc | Sledge Charles M | Dir | S - Sale | $44.63 | -2,083 | 2,084 | -50% | -$92,971 | ||||||
| M | 2026-02-18 | SSTI | Soundthinking, Inc. | Veradace Partners LP | 10% | P - Purchase | $7.13 | +114,628 | 2,017,116 | +6% | +$817,832 | |||||
2026-02-19 | WY | Weyerhaeuser Co | Beckwitt Richard | Dir | P - Purchase | $25.70 | +20,000 | 24,066 | +492% | +$514,000 | ||||||
| M | 2026-02-19 | ENSG | Ensign Group, Inc | Uychiat Pison Marivic | Dir | S - Sale | $208.29 | -150 | 14,340 | -1% | -$31,244 | |||||
2026-02-13 | ODCYX | Accordant Odce Index Fund | Hime James | CFO | P - Purchase | $9.26 | +5,400 | 5,400 | New | +$50,000 | ||||||
2026-02-18 | MAPS | Wm Technology, Inc. | Griffis Sarah | CTO | S - Sale | $0.68 | -271,032 | 1,528,968 | -15% | -$183,326 | ||||||
| DM | 2026-02-19 | QS | Quantumscape Corp | Holme Timothy | CTO | S - Sale+OE | $7.08 | -195,451 | 1,088,228 | -15% | -$1,383,384 | |||||
2026-02-18 | MAPS | Wm Technology, Inc. | Camire Brian | GC | S - Sale | $0.68 | -101,209 | 1,741,653 | -5% | -$68,458 | ||||||
2026-02-19 | QS | Quantumscape Corp | Straubel Jeffrey B | Dir | S - Sale | $7.10 | -27,106 | 212,616 | -11% | -$192,461 | ||||||
2026-02-18 | MAPS | Wm Technology, Inc. | Francis Douglas | CEO, 10% | S - Sale | $0.68 | -103,019 | 31,437,969 | 0% | -$69,682 | ||||||
| D | 2026-02-19 | DOV | Dover Corp | Tobin Richard J | COB, Pres, CEO | S - Sale+OE | $232.70 | -76,997 | 295,599 | -21% | -$17,917,202 | |||||
2026-02-19 | TEM | Tempus Ai, Inc. | Phelps Erik | EVP, Chief Admin. Officer | S - Sale | $59.43 | -9,464 | 79,816 | -11% | -$562,473 | ||||||
2026-02-19 | TEM | Tempus Ai, Inc. | Bartolucci Ryan M | Chief Accounting Officer | S - Sale | $59.05 | -2,902 | 54,157 | -5% | -$171,363 | ||||||
| M | 2026-02-19 | TEM | Tempus Ai, Inc. | Polovin Andrew | EVP, GC | S - Sale | $59.77 | -19,092 | 126,918 | -13% | -$1,141,136 | |||||
2026-02-19 | TEM | Tempus Ai, Inc. | Fukushima Ryan | CEO, Data | S - Sale | $59.05 | -9,592 | 918,155 | -1% | -$566,408 | ||||||
2026-02-19 | TEM | Tempus Ai, Inc. | Rogers James William | CFO | S - Sale | $59.05 | -10,084 | 138,662 | -7% | -$595,460 | ||||||
2026-02-18 | META | Meta Platforms, Inc. | Bosworth Andrew | CTO | S - Sale | $631.24 | -8,089 | 69,170 | -10% | -$5,106,082 | ||||||
| M | 2026-02-18 | MPLT | Maplight Therapeutics, Inc. | Pavlov George | Dir | P - Purchase | $17.65 | +25,000 | 25,000 | New | +$441,168 | |||||
2026-02-19 | AVAV | Aerovironment Inc | Page Stephen F | Dir | S - Sale | $275.00 | -250 | 51,956 | 0% | -$68,750 | ||||||
| D | 2026-02-19 | HON | Honeywell International Inc | Davis D Scott | Dir | S - Sale+OE | $240.00 | -2,367 | 31,081 | -7% | -$568,080 | |||||
| M | 2026-02-18 | CVLG | Covenant Logistics Group, Inc. | Parker David Ray | COB, CEO, 10% | S - Sale | $29.32 | -150,400 | 7,052,085 | -2% | -$4,410,135 | |||||
| D | 2026-02-20 | LFUS | Littelfuse Inc /De | Hunter Gordon | Dir | S - Sale+OE | $367.68 | -911 | 26,789 | -3% | -$334,958 | |||||
2026-02-18 | CWAN | Clearwater Analytics Holdings, Inc. | Sethi Subi | Chief Client Officer | S - Sale | $23.44 | -76,689 | 365,490 | -17% | -$1,797,721 | ||||||
2026-02-18 | CWAN | Clearwater Analytics Holdings, Inc. | Cox James S | CFO | S - Sale | $23.44 | -93,930 | 474,114 | -17% | -$2,201,879 | ||||||
2026-02-18 | CWAN | Clearwater Analytics Holdings, Inc. | Sahai Sandeep | CEO | S - Sale | $23.44 | -233,813 | 1,357,138 | -15% | -$5,480,974 | ||||||
2026-02-18 | CWAN | Clearwater Analytics Holdings, Inc. | Erickson Scott Stanley | Chief Revenue Officer | S - Sale | $23.44 | -74,530 | 138,630 | -35% | -$1,747,110 | ||||||
2026-02-18 | CWAN | Clearwater Analytics Holdings, Inc. | Das Souvik | CTO | S - Sale | $23.44 | -88,848 | 207,132 | -30% | -$2,082,748 | ||||||
| M | 2026-02-18 | LOB | Live Oak Bancshares, Inc. | Mahan James S III | CEO, 10% | S - Sale | $40.18 | -20,000 | 6,434,875 | 0% | -$803,598 | |||||
| M | 2026-02-17 | NAII | Natural Alternatives International Inc | Ledoux Mark A | CEO, COB, 10% | P - Purchase | $2.58 | +4,500 | 721,542 | +1% | +$11,604 | |||||
| M | 2026-02-18 | JOE | St Joe Co | Berkowitz Bruce R | 10% | S - Sale | $71.22 | -16,000 | 16,741,990 | 0% | -$1,139,546 | |||||
2026-02-20 | CWBC | Community West Bancshares | Stovesand Kirk | Dir | P - Purchase | $24.50 | +376 | 78,612 | 0% | +$9,212 | ||||||
2026-02-19 | TEAM | Atlassian Corp | Liu Gene | Chief Accounting Officer | S - Sale | $81.36 | -66 | 60,474 | 0% | -$5,370 | ||||||
2026-02-19 | TEAM | Atlassian Corp | Duffy Brian | Chief Revenue Officer | S - Sale | $81.35 | -1,222 | 124,332 | -1% | -$99,410 | ||||||
2026-02-19 | TEAM | Atlassian Corp | Rajan Rajeev Bashyam | CTO | S - Sale | $81.35 | -3,072 | 212,916 | -1% | -$249,907 | ||||||
| D | 2026-02-18 | WCC | Wesco International Inc | Kulasa Matthew S | SVP, Corp. Controller, CAO | S - Sale+OE | $307.03 | -73 | 4,019 | -2% | -$22,413 | |||||
| D | 2026-02-18 | IR | Ingersoll Rand Inc. | Reynal Vicente | See Remarks | S - Sale+OE | $100.00 | -900 | 438,488 | 0% | -$90,000 | |||||
2026-02-19 | PFSI | Pennymac Financial Services, Inc. | Spector David | COB, CEO | S - Sale | $94.51 | -12,950 | 632,336 | -2% | -$1,223,855 | ||||||
2026-02-19 | TEAM | Atlassian Corp | Binz Joseph Leo | CFO | S - Sale | $81.35 | -1,653 | 208,639 | -1% | -$134,471 | ||||||
2026-02-18 | BLKB | Blackbaud Inc | Benjamin David J | EVP, Chief Commercial Officer | S - Sale | $49.41 | -7,990 | 89,527 | -8% | -$394,771 | ||||||
| D | 2026-02-18 | PLMR | Palomar Holdings, Inc. | Uchida T Christopher | CFO | S - Sale+OE | $128.04 | -783 | 14,752 | -5% | -$100,255 | |||||
| D | 2026-02-18 | PLMR | Palomar Holdings, Inc. | Christianson Jon | Pres | S - Sale+OE | $128.04 | -522 | 65,919 | -1% | -$66,837 | |||||
| D | 2026-02-18 | PLMR | Palomar Holdings, Inc. | Knutzen Jonathan | Chief Risk Officer | S - Sale+OE | $128.04 | -281 | 27,579 | -1% | -$35,979 | |||||
| D | 2026-02-19 | CRSP | Crispr Therapeutics AG | Kulkarni Samarth | CEO | S - Sale+OE | $52.58 | -6,967 | 226,106 | -3% | -$366,325 | |||||
| D | 2026-02-19 | CRSP | Crispr Therapeutics AG | Kasinger James R. | GC, Secretary | S - Sale+OE | $52.58 | -2,112 | 85,115 | -2% | -$111,049 | |||||
2026-02-18 | TNET | Trinet Group, Inc. | Treadway Anthony Shea | SVP, Chief Revenue Officer | S - Sale | $41.81 | -487 | 27,006 | -2% | -$20,361 | ||||||
2026-02-19 | DKNG | Draftkings Inc. | Bradbury Erik | Chief Accounting Officer | S - Sale | $22.50 | -7,268 | 36,736 | -17% | -$163,530 | ||||||
| D | 2026-02-18 | USFD | Us Foods Holding Corp. | Works James David Jr | See Remarks | S - Sale+OE | $96.52 | -65,737 | 88,176 | -43% | -$6,345,128 | |||||
| D | 2026-02-20 | KYMR | Kymera Therapeutics, Inc. | Esposito Pamela | Dir | S - Sale+OE | $87.31 | -2,500 | 0 | -100% | -$218,270 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |